Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes
- PMID: 30787056
- PMCID: PMC6973546
- DOI: 10.2337/dci18-0040
Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes
Comment on
-
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.Diabetes Care. 2019 Mar;42(3):400-405. doi: 10.2337/dc18-1444. Epub 2018 Oct 23. Diabetes Care. 2019. PMID: 30352896 Free PMC article.
References
-
- Nathan DM, Genuth S, Lachin J, et al. .; Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986 - PubMed
-
- Lu J, Ma X, Zhou J, et al. . Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care 2018;41:2370–2376 - PubMed
-
- Agiostratidou G, Anhalt H, Ball D, et al. . Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017;40:1622–1630 - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
